Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children

Mohamed Rachid Boulassel, Johanne Samson, Ampha Khammy, Normand Lapointe, Hugo Soudeyns, Jean Pierre Routy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We recently reported that interleukin-7 (IL-7), a potent stimulator of lymphopoiesis, is an independent predictor of virological response to antiretroviral therapy (ART) in HIV-1 infected adults. To determine if this cytokine also predicts treatment response in HIV-1-infected children, a longitudinal study was performed over 48 weeks in 36 treatment-naïve children vertically infected with HIV-1. Subjects who received treatment (n = 29) were stratified as complete virological responders (n = 12), partial virological responders (n = 11), or non-responders (n = 6), based on decline in viral load from baseline to week 48. Median plasma IL-7 levels at baseline were higher in complete responders (4.85 pg/mL, interquartile range [IQR] = 3.35-6.5) than in untreated controls (2.10 pg/mL, IQR = 1.50-3.50; p = 0.05). Linear regression analysis showed that baseline IL-7 levels were positively correlated with changes in HIV-1 viral load between baseline and week 24 (r = 0.40; p = 0.03) and between baseline and week 48 (r = 0.34; p = 0.07), but not with corresponding changes in CD4+ T-cell percentages and absolute counts. Collectively, these results indicate that IL-7 levels at baseline are predictive of virological but not immunological response to ART in children infected with HIV-1.

Original languageEnglish
Pages (from-to)649-656
Number of pages8
JournalViral Immunology
Volume20
Issue number4
DOIs
Publication statusPublished - Dec 1 2007

Fingerprint

Interleukin-7
HIV-1
Viral Load
Lymphopoiesis
Therapeutics
Longitudinal Studies
Linear Models
Regression Analysis
Cytokines
T-Lymphocytes

ASJC Scopus subject areas

  • Immunology
  • Molecular Medicine
  • Virology

Cite this

Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children. / Boulassel, Mohamed Rachid; Samson, Johanne; Khammy, Ampha; Lapointe, Normand; Soudeyns, Hugo; Routy, Jean Pierre.

In: Viral Immunology, Vol. 20, No. 4, 01.12.2007, p. 649-656.

Research output: Contribution to journalArticle

Boulassel, Mohamed Rachid ; Samson, Johanne ; Khammy, Ampha ; Lapointe, Normand ; Soudeyns, Hugo ; Routy, Jean Pierre. / Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children. In: Viral Immunology. 2007 ; Vol. 20, No. 4. pp. 649-656.
@article{e019fe424d804910ad80673b2f10ea80,
title = "Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children",
abstract = "We recently reported that interleukin-7 (IL-7), a potent stimulator of lymphopoiesis, is an independent predictor of virological response to antiretroviral therapy (ART) in HIV-1 infected adults. To determine if this cytokine also predicts treatment response in HIV-1-infected children, a longitudinal study was performed over 48 weeks in 36 treatment-na{\"i}ve children vertically infected with HIV-1. Subjects who received treatment (n = 29) were stratified as complete virological responders (n = 12), partial virological responders (n = 11), or non-responders (n = 6), based on decline in viral load from baseline to week 48. Median plasma IL-7 levels at baseline were higher in complete responders (4.85 pg/mL, interquartile range [IQR] = 3.35-6.5) than in untreated controls (2.10 pg/mL, IQR = 1.50-3.50; p = 0.05). Linear regression analysis showed that baseline IL-7 levels were positively correlated with changes in HIV-1 viral load between baseline and week 24 (r = 0.40; p = 0.03) and between baseline and week 48 (r = 0.34; p = 0.07), but not with corresponding changes in CD4+ T-cell percentages and absolute counts. Collectively, these results indicate that IL-7 levels at baseline are predictive of virological but not immunological response to ART in children infected with HIV-1.",
author = "Boulassel, {Mohamed Rachid} and Johanne Samson and Ampha Khammy and Normand Lapointe and Hugo Soudeyns and Routy, {Jean Pierre}",
year = "2007",
month = "12",
day = "1",
doi = "10.1089/vim.2007.0047",
language = "English",
volume = "20",
pages = "649--656",
journal = "Viral Immunology",
issn = "0882-8245",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Predictive value of interleukin-7 levels for virological response to treatment in HIV-1-infected children

AU - Boulassel, Mohamed Rachid

AU - Samson, Johanne

AU - Khammy, Ampha

AU - Lapointe, Normand

AU - Soudeyns, Hugo

AU - Routy, Jean Pierre

PY - 2007/12/1

Y1 - 2007/12/1

N2 - We recently reported that interleukin-7 (IL-7), a potent stimulator of lymphopoiesis, is an independent predictor of virological response to antiretroviral therapy (ART) in HIV-1 infected adults. To determine if this cytokine also predicts treatment response in HIV-1-infected children, a longitudinal study was performed over 48 weeks in 36 treatment-naïve children vertically infected with HIV-1. Subjects who received treatment (n = 29) were stratified as complete virological responders (n = 12), partial virological responders (n = 11), or non-responders (n = 6), based on decline in viral load from baseline to week 48. Median plasma IL-7 levels at baseline were higher in complete responders (4.85 pg/mL, interquartile range [IQR] = 3.35-6.5) than in untreated controls (2.10 pg/mL, IQR = 1.50-3.50; p = 0.05). Linear regression analysis showed that baseline IL-7 levels were positively correlated with changes in HIV-1 viral load between baseline and week 24 (r = 0.40; p = 0.03) and between baseline and week 48 (r = 0.34; p = 0.07), but not with corresponding changes in CD4+ T-cell percentages and absolute counts. Collectively, these results indicate that IL-7 levels at baseline are predictive of virological but not immunological response to ART in children infected with HIV-1.

AB - We recently reported that interleukin-7 (IL-7), a potent stimulator of lymphopoiesis, is an independent predictor of virological response to antiretroviral therapy (ART) in HIV-1 infected adults. To determine if this cytokine also predicts treatment response in HIV-1-infected children, a longitudinal study was performed over 48 weeks in 36 treatment-naïve children vertically infected with HIV-1. Subjects who received treatment (n = 29) were stratified as complete virological responders (n = 12), partial virological responders (n = 11), or non-responders (n = 6), based on decline in viral load from baseline to week 48. Median plasma IL-7 levels at baseline were higher in complete responders (4.85 pg/mL, interquartile range [IQR] = 3.35-6.5) than in untreated controls (2.10 pg/mL, IQR = 1.50-3.50; p = 0.05). Linear regression analysis showed that baseline IL-7 levels were positively correlated with changes in HIV-1 viral load between baseline and week 24 (r = 0.40; p = 0.03) and between baseline and week 48 (r = 0.34; p = 0.07), but not with corresponding changes in CD4+ T-cell percentages and absolute counts. Collectively, these results indicate that IL-7 levels at baseline are predictive of virological but not immunological response to ART in children infected with HIV-1.

UR - http://www.scopus.com/inward/record.url?scp=37549054012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549054012&partnerID=8YFLogxK

U2 - 10.1089/vim.2007.0047

DO - 10.1089/vim.2007.0047

M3 - Article

C2 - 18158737

AN - SCOPUS:37549054012

VL - 20

SP - 649

EP - 656

JO - Viral Immunology

JF - Viral Immunology

SN - 0882-8245

IS - 4

ER -